maximizing the potential of immunotherapy in unresectable stage iii nsclc
Published 2 years ago • 835 plays • Length 1:11:21Download video MP4
Download video MP3
Similar videos
-
1:08:00
has immunotherapy brought us to an inflection point in the management of stage i-iii nsclc?
-
33:06
maximizing the of potential current and emerging immunotherapies in advanced endometrial cancer
-
1:05:29
can the addition of immunotherapy to multimodal management of stage i-iii nsclc improve outcomes?
-
43:35
maximizing the impact of egfr-targeted therapy in resectable nsclc
-
1:03:31
elevating care in resectable stage i-iii nsclc
-
47:55
advanced gastroesophageal cancers: maximizing the benefits of novel immunotherapy approaches
-
21:36
are we closer to a cure with perioperative immunotherapy in resectable nsclc?
-
15:25
targeted therapies: the future of non-small cell lung cancer (nsclc) treatment?
-
1:06:23
immunotherapy in lung cancer: rationale, evidence, and implications for the multidisciplinary team
-
59:24
marking new milestones with immunotherapy in locally advanced and early lung cancer
-
59:37
marking new milestones with immunotherapy in locally advanced and early lung cancer
-
36:55
immunotherapy in lung cancer: rationale, evidence, and implications for the multidisciplinary team
-
1:27:28
the continuing success story of immunotherapy in nsclc
-
7:44
immunotherapy in stage iii nsclc
-
2:22
moving immunotherapy to earlier lines in nsclc
-
56:08
gaining confidence in predicting and assessing response to cancer immunotherapies
-
1:44:45
gaining an advantage over nsclc: how to achieve the greatest benefit with immunotherapy
-
2:34
dr. langer on practice-changing pacific data in stage iii nsclc
-
0:53
dr. schwartz on the results of the pacific trial